The Motor Neuron Diseases Working Group of EURO-NMD is proud to launch a special ALS Webinar Series in March 2026.
This three-part series will spotlight major advances in our understanding of Amyotrophic Lateral Sclerosis (ALS), bringing together internationally recognised experts who are shaping the future of research and clinical practice.
From better understanding non-motor symptoms, to innovative biomarker-driven trial platforms, and new insights into pre-symptomatic ALS and disease prevention, these sessions will offer a dynamic overview of where the field is heading.
Each webinar will feature a keynote lecture followed by expert moderation and discussion, providing a valuable opportunity to learn, exchange ideas, and connect with the neuromuscular community across Europe and beyond.
Programme
Episode 1:
5 March 2026 – 16:00 CET
“Autonomic and non-motor symptoms in ALS”
Speaker: Prof. Ammar Al-Chalabi (King’s College London, UK)
Moderator: Prof. Vincenzo Silani (IRCCS Istituto Auxologico Italiano, Milan, Italy)
Episode 2:
12 March 2026 – 16:00 CET
“EXPERTS-ALS – a Bayesian biomarker-led drug screening platform in ALS”
Speaker: Prof. Martin Turner (University of Oxford, UK)
Moderator: Prof. Philippe Corcia (Department of Neurology, Tours University Hospital (CHRU de Tours))
Episode 3:
19 March 2026 – 16:00 CET
“Advances in understanding pre-symptomatic ALS: implications for disease prevention”
Speaker: Michael Benatar (University of Miami, USA)
Moderator: Prof. Vincenzo Silani (IRCCS Istituto Auxologico Italiano, Milan, Italy)